A Comparative Pharmacokinetic Evaluation of Paliperidone Palmitate Extended-Release Injectable Suspensions: An Open Label, Randomized, Two treatment, Two-Period, Two-Sequence, Multiple Dose, Steady State Crossover Bioequivalence Study in Patients with Schizophrenia and/or Schizoaffective Disorder
Test(T)) manufactured by Sun Pharmaceuticals Industries Limited compared to paliperidone palmitate ER Injectable suspension (Invega Sustenna®) (Reference(R)) manufactured by Janssen Pharmaceuticals in patients with…

